Literature DB >> 17640483

11 beta-hydroxysteroid dehydrogenase type 1 promotes differentiation of 3T3-L1 preadipocyte.

Yun Liu1, Yan Sun, Ting Zhu, Yu Xie, Jing Yu, Wen-lan Sun, Guo-xian Ding, Gang Hu.   

Abstract

AIM: To investigate the relationship between 11 beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), a potential link between obesity and type 2 diabetes, and preadipocyte differentiation.
METHODS: Mouse 11beta-HSD1 siRNA plasmids were transfected into 3T3-L1 preadipocytes (a cell line derived from mouse Swiss3T3 cells that were isolated from mouse embryo), for examination of the effect of targeted 11beta-HSD1 inhibition on differentiation of 3T3-L1 cells. Differentiation was stimulated with 3-isobutyl-1-methyxanthine, insulin, and dexamethasone. The transcription level of the genes was detected by real-time PCR.
RESULTS: Lipid accumulation was significantly inhibited in cells transfected with mouse 11beta-HSD1 siRNA compared with non-transfected 3T3-L1 cells. Fewer lipid droplets were detected in the transfected cells both prior to stimulation and after stimulation with differentiation-inducing reagents. The expression of adipocyte differentiation-associated markers such as lipoprotein lipase and fatty acid synthetase were downregulated in the transfected cells. Similarly, the expression of preadipocyte factor-1, an inhibitor of adipocyte differentiation, was downregulated upon stimulation of differentiation and had no changes in the transfected cells.
CONCLUSION: 11 beta-HSD1 can promote preadipocyte differentiation. Based on this, we propose that 11 beta-HSD1 may be an important candidate mediator of obesity and obesity-induced insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640483     DOI: 10.1111/j.1745-7254.2007.00602.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  4 in total

1.  Equisetin is an anti-obesity candidate through targeting 11β-HSD1.

Authors:  Zhenlu Xu; Dongyun Liu; Dong Liu; Xue Ren; Haibo Liu; Guihong Qi; Yue Zhou; Chongming Wu; Kui Zhu; Zhongmei Zou; Jing Yuan; Wenhan Lin; Peng Guo
Journal:  Acta Pharm Sin B       Date:  2022-01-15       Impact factor: 14.903

2.  Development of a high-throughput cell-based assay for 11beta-hydroxysteroid dehydrogenase type 1 using BacMam technology.

Authors:  Da-Yuan Wang; Quinn Lu; Stacey L Walsh; Lisa Payne; Sundip S Modha; Martin J Scott; Thomas D Sweitzer; Robert S Ames; Daniel J Krosky; Hu Li
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

3.  S100A16-induced adipogenesis is associated with up-regulation of 11 β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).

Authors:  Rihua Zhang; Jing Bao Kan; Shan Lu; Pei Tong; Jie Yang; Ling Xi; Xiubing Liang; Dongming Su; Dong Li; Yun Liu
Journal:  Biosci Rep       Date:  2019-09-09       Impact factor: 3.840

4.  Novel small molecule 11β-HSD1 inhibitor from the endophytic fungus Penicillium commune.

Authors:  Weiguang Sun; Xintao Chen; Qingyi Tong; Hucheng Zhu; Yan He; Liang Lei; Yongbo Xue; Guangmin Yao; Zengwei Luo; Jianping Wang; Hua Li; Yonghui Zhang
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.